Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Ayolola Eni‐Olotu

Biographic Data

ID7990246
NAMEAyolola Eni‐Olotu
GIVEN NAMESAyolola
FAMILY NAMEEni‐Olotu
SIGNATUREOLOTU A E
AFFILIATIONSImperial College London
ORCID0000-0002-9187-9692
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Achieving equitable access to health technologies during a pandemic

    Open Access•Ayolola Eni‐Olotu, Rebecca Hotchkin et al.•ARTICLE•Global Public Health•2025

    The COVID-19 pandemic underlined stark inequalities in timely access to health technologies worldwide. Universities, by conducting a significant amount of early biomedical research and development, have a critical but often overlooked role in determining downstream equitable access to health technologies. This paper reviews university's policies and practices regarding COVID-19 health technologies in the United Kingdom (UK) during the recent pand…

  • Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine

    Open Access•Samuel Cross, Yeanuk Rho et al.•ARTICLE•BMJ Global Health•2021

    OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…

No prominent works on this page.

  • Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine

    Open Access•Samuel Cross, Yeanuk Rho et al.•ARTICLE•BMJ Global Health•2021

    OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…

  • Achieving equitable access to health technologies during a pandemic

    Open Access•Ayolola Eni‐Olotu, Rebecca Hotchkin et al.•ARTICLE•Global Public Health•2025

    The COVID-19 pandemic underlined stark inequalities in timely access to health technologies worldwide. Universities, by conducting a significant amount of early biomedical research and development, have a critical but often overlooked role in determining downstream equitable access to health technologies. This paper reviews university's policies and practices regarding COVID-19 health technologies in the United Kingdom (UK) during the recent pand…

Medicine (2 works) · Political science (2 works) · 2019-20 coronavirus outbreak (1 work) · Biomedical Ethics and Regulation (1 work) · Business (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Disease (1 work) · Economic growth (1 work) · Economics (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae